Comments
  • Daniel Haszard January 7, 2010 at 4:41 pm

    Addictive Zyprexa was pushed by Lilly Drug Reps.

    They called it the "Five at Five" (5 mg at 5 pm to keep nursing home patients subdued and sleepy) and "VIVA ZYPREXA" (Zyprexa for everybody) campaigns to off label market Eli Lilly Zyprexa as a fix for unapproved usage.

    Daniel Haszard

  • Sharon McEachern January 10, 2010 at 1:59 pm

    I think it's interesting to combine both this post on off-label uses of prescription drugs and Heidi Turner's article "Paxil and Other Antidepressants May Treat only Severe Depression" January 10, here in Lawyers and Settlements.com.

    None of the articles I've read in the news on these topics even mention the resulting ethical conundrums, which of course can translate into legal action. How about the patients involved in the research? There's an ethical obligation toward those who are randomly asssigned to get a placebo. (Don't forget, to prove the efficacy of a drug, it must work better than a placebo.)

    Of the 164 million prescriptions written for antidepressants in America in 2008, totaling almost $10 billion in sales, about 70 percent of the patients have moderate to mild symptoms and receive as much help from taking placebos as the antidepressant drug. Ethic Soup blog has an excellent post on the subject.

  • Leave a Reply

REQUEST LEGAL HELP NOW

Share this Page

RSS Feed

Find us on

Find us on FacebookFollow us on TwitterFind us on LinkedInFind us on Foursquare

Our Facebook Activity